Candel Therapeutics is pushing for a paradigm shift in cancer treatment

Cancer treatment has long been dominated by traditional approaches such as surgery, radiation, and chemotherapy. But in recent years, a wave of innovation has emerged, driven by the promise of immunotherapies that harness the body's own immune system to fight cancer. Among the companies at the forefront is Candel Therapeutics Inc (NASDAQ:CADL), a biotech company dedicated to creating transformative cancer therapies. With its lead candidate, CAN-2409, and a promising pipeline, Candel aims to bring new hope t ...